PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
16-Aug-2022 OKYO Pharma Limited - Final audited results for the year ended 31 March 2022 OKYO Pharma Limited
16-Aug-2022 Formycon's Biosimilar Ustekinumab Candidate FYB202 Shows Comparable Efficacy to Reference Product Stelara®* in Phase III Study Formycon AG
16-Aug-2022 Straumann Group reports over CHF 1 billion in the first half of 2022 Straumann Holding AG
16-Aug-2022 Medartis reports 20% sales growth and makes further progress in strengthening its US organisation Medartis Holding AG
15-Aug-2022 Medicines and Healthcare Products Regulatory Agency (MHRA) Authorizes Moderna's Omicron-Containing Bivalent Booster in the UK Moderna, Inc.
15-Aug-2022 Epigenomics AG: Notice of Loss pursuant to Sec. 92 par. 1 AktG Epigenomics AG
12-Aug-2022 Heidelberg Pharma AG Launches Rights Issue of up to EUR 80 Million Heidelberg Pharma AG
12-Aug-2022 Q2/2022: Sales of EUR 2.7 million and EBITDA of EUR -0.2 million below expectations in persistently challenging macroeconomic environment; growth expected for second half of 2022 aap Implantate AG
12-Aug-2022 Relief Therapeutics and Acer Therapeutics Announce that the European Commission Has Granted Orphan Drug Designation for ACER-001 in Maple Syrup Urine Disease Relief Therapeutics Holding SA
11-Aug-2022 F-star Therapeutics Reports Second Quarter 2022 Financial Results and Corporate Highlights F-star Therapeutics
11-Aug-2022 argenx Announces European Commission Approval of VYVGART™ (efgartigimod alfa-fcab) for the Treatment of Generalized Myasthenia Gravis argenx
11-Aug-2022 MHRA grants marketing authorisation for Novartis’ radioligand therapy Pluvicto®▼ (lutetium (177Lu) vipivotide tetraxetan) in advanced prostate cancer in Great Britain Novartis
11-Aug-2022 Nouscom announces leading publication revealing an immune mechanism of action driving anti-tumor activity of adenovirus vectored vaccines and anti-PD1 immunotherapy Nouscom
11-Aug-2022 iTeos Reports Second Quarter 2022 Financial Results and Provides Business Update iTeos
11-Aug-2022 Genmab Announces Financial Results for the First Half of 2022 Genmab
11-Aug-2022 ​​​​​​​Eckert & Ziegler with Successful First Half of 2022 Eckert & Ziegler Strahlen- und Medizintechnik AG
11-Aug-2022 Medios AG continues record course: Strong growth in the first half of 2022 Medios AG
11-Aug-2022 APONTIS PHARMA expands profitable positioning in first half of 2022 – full-year forecast confirmed APONTIS PHARMA AG
11-Aug-2022 Evotec SE reports results for the first half-year 2022 and provides corporate updates Evotec SE
11-Aug-2022 SYNLAB reports solid H1 2022 results and raises 2022 revenue guidance SYNLAB AG